We thus explored the capacity of purified CD8+ T-cells from 48 patients from the ANRS 147 OPTIPRIM study to suppress HIV-1 infection of autologous CD4+ T-cells ex vivo. This evidence concerns the gene CD8A and HIV-1 infection.